Efficacy and safety of the switch of Triumeq® to generic (abacavir + lamivudine) + Tivicay®: data at 24 weeks. - Olalla J; Pérez-Stachowski J; Tortajada B; Del Arco A; Márquez E; De la Torre J; Nieto M; García de Lomas JM; Prada JL; García-Alegría J (BMC pharmacology & toxicology, 2018)